MedReleaf Corp. is a listed company. Its insiders report their share dealings to SEDI. Nothing new has been filed by managers of MedReleaf Corp. in twelve months, the latest record being from 27 July 2018.
Our records for MedReleaf Corp. go back to 2017, with no purchases and 65 sales on the open market in total.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 120 declarations
MedReleaf Corp. is a Canadian company focused on the production of medical cannabis. It is listed on the Toronto Stock Exchange under the symbol XTSE.